The shingles vaccine may offer a protective effect against developing dementia, as well as “therapeutic potential” for those ...

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price onDecember 23, 2025 EMERYVILLE, Calif., Dec. 24, 2025 /PRNewswire/ -- ...

Dynavax's adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than ...

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an ...

If you're over age 50 or have a suppressed immune system, you may have heard your doctor recommend the shingles vaccine. But ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? A study published last April found that the likelihood of receiving a dementia ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...

The shingles vaccine may both reduce and slow down dementia. The corresponding study was published in Cell. On September 1st 2013, Wales launched a national vaccination program in which anyone aged 79 ...

If you’re in your 40s, shingles isn’t just an older-adult problem—it’s the chickenpox virus waking up decades later, and it can hit you now. Getting it before age 50 significantly raises your chances ...

New research finds that the shingles vaccine could reduce the likelihood of developing dementia and may even slow the disease in people that have already been diagnosed. With dementia cases expected ...

A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in people who have already been diagnosed with the disease. Researchers are ...